Detalles de la búsqueda
1.
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Breast Cancer Res Treat
; 173(1): 123-133, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30242578
2.
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Breast Cancer Res Treat
; 168(1): 69-77, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128898
3.
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
BMC Cancer
; 18(1): 526, 2018 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728098
4.
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.
Breast Cancer Res
; 17(1): 133, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429296
5.
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Breast Cancer Res Treat
; 152(2): 389-98, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26119102
6.
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies.
BMC Genomics
; 14: 690, 2013 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24103217
7.
Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.
Curr Alzheimer Res
; 4(5): 562-7, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18220523
8.
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
J Natl Cancer Inst
; 109(4)2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053207
9.
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
J Natl Cancer Inst
; 109(4)2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28122895
10.
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.
Oncotarget
; 7(23): 33855-65, 2016 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121323
11.
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Adv Ther
; 32(12): 1237-47, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26610383
12.
Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists.
J Med Chem
; 46(11): 2177-86, 2003 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-12747789
13.
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eur Urol
; 66(3): 550-60, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24836057
14.
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
J Natl Cancer Inst
; 105(10): 701-10, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23641039
15.
Characterization and functionality of proliferative human Sertoli cells.
Cell Transplant
; 20(5): 619-35, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21054948
16.
Agonist-induced calcium response in single human platelets assayed in a microfluidic device.
Anal Biochem
; 341(2): 361-8, 2005 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15907883
17.
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.
Bioorg Med Chem Lett
; 12(21): 3085-8, 2002 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-12372507
Resultados
1 -
17
de 17
1
Próxima >
>>